Hiran Ratnayake
Senior Communications Manager
Department of External Affairs
Request an Interview

Christiana Care Health System Joins American Hospital Association Pledge to Ensure Good Stewardship of 340B Drug Pricing Program

In its commitment to transparency and raising awareness about community investments to help its neighbors achieve optimal health, Christiana Care Health System announced today that it is pledging commitment to the American Hospital Association’s Good Stewardship Principles for the 340B Drug Discount Program.

The 340B Drug Discount Program was created by Congress in 1992 under the Public Health Service Act to protect safety net hospitals from escalating drug prices.

Hospitals that participate in the Good Stewardship Principles have committed to ensuring good stewardship and greater transparency, highlighting the immense value of the program, which ultimately helps low-income and underinsured patients.

“Taking the American Hospital Association Good Stewardship pledge is the right thing to do for our community,” said Janice E. Nevin, M.D., MPH, president and chief executive officer. “These principles are consistent with Christiana Care’s values of excellence and love, as we strive to make a positive impact on the health of our community through innovative, high-quality, accessible, affordable care.”

Under the pledge, hospitals make a commitment to communicate the value of the 340B program, disclose 340B estimated savings annually and provide internal oversight to ensure that the hospital 340B program meets the U.S. Health Resources and Services Administration’s program rules and guidance.

The 340B program is designed to allow certain safety net hospitals – such as Christiana Care – and other covered entities that serve a large number of uninsured and underinsured patients to purchase outpatient drugs at a discount directly from drug manufacturers. It is designed, as the law states, “to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”

Christiana Care joined the 340B Drug Discount Program in 2018.

“Savings earned through our participation in the 340B program will be invested into our overall efforts to address social determinants of health in our community,” said Bettina Tweardy Riveros, Esq., chief health equity officer at Christiana Care. “Through innovative programs and strategic partnerships, we are addressing critical needs in our community that directly impact health and advance health equity. These needs include greater access to medical and dental care, housing, food, transportation, youth programs, workforce development, financial literacy and economic mobility.”

Savings from the program have already contributed to these efforts. In March, Christiana Care announced a $1 million investment in the REACH Riverside Development Corporation to support community health and youth development programs in Riverside, one of the city’s oldest and most underserved neighborhoods.

The pledge also aligns with Christiana Care’s commitment to transparency. Christiana Care commits to publicly disclosing, on an annual basis, its 340B estimated savings calculated using a standardized method.

“We are committed to transparency as we work to ensure that our high-quality care is delivered at an affordable cost,” said Rob McMurray, chief financial officer at Christiana Care. “The 340B program provides us with guidelines on how we can ensure the community benefits from these savings. We are currently developing a plan for how we will share this information with our community on a yearly basis, in conjunction with our continuous work to assess the health needs of our community and develop strategies to address them.”

This pledge comes on the heels of another transformative endeavor by Christiana Care to help reduce drug costs to patients. In March, Christiana Care announced that it had joined Civica Rx, a new nonprofit organization created to give health systems access to reliable generic drugs at an appropriate price and to create greater stability and predictability in the supply chain of many generic medications.


Need an expert source?

Our Experts, ChristianaCare's expert database, can help you find the right source for your next news story.

Request an interview ➜

About ChristianaCare

Headquartered in Wilmington, Delaware, ChristianaCare is one of the country’s most dynamic health care organizations, centered on improving health outcomes, making high-quality care more accessible and lowering health care costs. ChristianaCare includes an extensive network of primary care and outpatient services, home health care, urgent care centers, three hospitals (1,430 beds), a freestanding emergency department, a Level I trauma center and a Level III neonatal intensive care unit, a comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care and women’s health. It also includes the pioneering Gene Editing Institute.

ChristianaCare is nationally recognized as a great place to work, rated by Forbes as the 2nd best health system for diversity and inclusion, and the 29th best health system to work for in the United States, and by IDG Computerworld as one of the nation’s Best Places to Work in IT. ChristianaCare is rated by Healthgrades as one of America’s 50 Best Hospitals and continually ranked among the nation’s best by U.S. News & World Report, Newsweek and other national quality ratings. ChristianaCare is a nonprofit teaching health system with more than 260 residents and fellows. With its groundbreaking Center for Virtual Health and a focus on population health and value-based care, ChristianaCare is shaping the future of health care.